Description
Latin name
Fibralax
Release form
Powder for preparation of suspension for oral administration
Indications
acute and chronic constipation
anal fissures
hemorrhoids
postoperative period for interventions in the anorectal region (in order to create a softer stool consistency).
Contraindications
Hypersensitivity to the components of the drug
concomitant use of MAO inhibitors
severe impairment of renal and / or liver function (glomerular filtration rate,
Use during pregnancy and lactation
Use of the drug during pregnancy and breastfeeding is possible as directed by a doctor.
Dosage and Administration
Inside. 1 sachet 1-3 times a day 30 minutes before meals or 2 hours after meals.
Before use, pour the contents of 1 sachet into a glass of cold water, stir and drink immediately, then drink another glass of liquid.
Side effects
Allergic reactions possible.
In the early days of treatment, a feeling of fullness in the abdomen may occur.
Drug Interaction
Do not use at the same time as antidiarrheal drugs, or drugs that inhibit bowel motility.
Fibralax can slow the absorption of concomitantly used medicines. The interval of 30-60 min between administration of Fnbralax and other drugs should be observed.
Storage conditions
Do not store above 25 ° C. Keep out of reach of children.
shelf life
3 years
Deystvuyushtee substance
Podorozhnika ovalynogo semyan obolochka
Conditions of release from
pharmacies Without prescription
dosage form
oral suspension
Possible product names
Firalax powder for suspension 5 g 20 pcs.
